Lv4
445 积分 2022-03-14 加入
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
2个月前
已完结
Atezolizumab plus lenvatinib for unresectable hepatocellular carcinoma: A phase 1b/2 trial
2个月前
已完结
The stigma of alcohol-related liver disease and its impact on healthcare
2个月前
已完结
92P Safety of liver resection following atezolizumab plus bevacizumab treatment in hepatocellular carcinoma (HCC) patients with macrovascular invasion: A pre-specified analysis of the TALENTop study
4个月前
已关闭
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
4个月前
已完结
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
6个月前
已完结
Phase I Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors
1年前
已完结
Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors
1年前
已完结
Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated Daily
1年前
已完结
皖公网安备34019202002308
